ScholarGate
アシスタント

手法を比較

選択した手法を並べて確認できます。異なる行はハイライト表示されます。

多施設共同第II相臨床試験×フェーズII臨床試験 ― 初期有効性と用量評価×
分野疫学疫学
系統Process / pipelineProcess / pipeline
提唱年1970s–1980s (formalized in regulatory guidance; Simon two-stage design 1989)1960s–1970s (formalised in US federal drug regulation)
提唱者Established through ICH and FDA regulatory frameworks; Simon two-stage design formalized by Richard Simon (1989)U.S. Food and Drug Administration / ICH E8 guidelines (institutionalised framework)
種類Interventional clinical trial designInterventional clinical study design
原典International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). (2009). ICH Harmonised Tripartite Guideline: General Considerations for Clinical Studies E8(R1). ICH. link ↗Friedman, L. M., Furberg, C. D., DeMets, D. L., Reboussin, D. M., & Granger, C. B. (2015). Fundamentals of Clinical Trials (5th ed.). Springer. ISBN: 978-3319185392
別名multi-site phase II trial, phase 2 multicenter study, multicenter Phase IIA/IIB trial, multisite efficacy trialPhase 2 trial, Phase II study, early efficacy trial, proof-of-concept trial
関連66
概要A multicenter phase II clinical trial is an interventional study conducted at two or more independent clinical sites to evaluate the preliminary efficacy and safety of a new treatment in a defined patient population, following demonstrated tolerability in phase I. By pooling patients across sites, the design achieves the sample sizes needed to estimate response rates and identify promising signals before committing to the larger investment of a phase III confirmatory trial.A Phase II clinical trial is the second stage in the drug or intervention development pipeline, conducted after Phase I safety testing. Its primary goal is to assess whether the intervention shows preliminary efficacy signals in a relevant patient population at the dose established in Phase I, while continuing to characterise the safety and tolerability profile. Phase II trials are generally smaller than Phase III confirmatory trials and serve as critical go/no-go decision points before large-scale investment.
ScholarGateデータセット
  1. v1
  2. 2 出典
  3. PUBLISHED
  1. v1
  2. 2 出典
  3. PUBLISHED

検索へ スライドをダウンロード

ScholarGate手法を比較: Multicenter phase II clinical trial · Phase II clinical trial. 2026-06-20に以下より取得 https://scholargate.app/ja/compare